FDA Approves Pfizer-BioNTech Booster Dose for Children Ages 5 to 11 as Cases Rise

Published May 18, 2022

Self reports that the FDA approved Pfizer-BioNTech’s booster dose for COVID-19 for children ages 5 to 11. Getting vaccinated and boosted is the best protection we have against severe COVID-19, which can lead to hospitalization or death. “Children are not bulletproof against COVID-19,” said Thomas A. Russo, MD, SUNY Distinguished Professor of medicine and chief of the Division of Infectious Diseases.